Protagenic Therapeutics, Inc.\new (PTIX): Operating Income

Annual figures by period end, from SEC filings.

-$4.50M

Year ended 2026-03-31

-$4.26M

Trailing 12 months to 2026-06-30

2014-06-30 Operating Income (USD) 2026-03-31

Period ended	Operating Income	Change YoY	Source filing
2026-03-31	-$4.50M	n/m	2026-08-14, From 2025-04-01
2025-03-31	-$2.59M	n/a	2026-08-14, From 2024-04-01
No annual figure between 2023-12-31 and 2025-03-31.
2023-12-31	-$4.53M	n/m	2025-03-31, From 2023-01-01
2022-12-31	-$3.56M	n/m	2024-05-14, From 2022-01-01
2021-12-31	-$4.14M	n/m	2023-03-31, From 2021-01-01
2020-12-31	-$2.55M	n/m	2022-04-07, From 2020-01-01
2019-12-31	-$2.09M	n/m	2021-03-25, From 2019-01-01
2018-12-31	-$2.31M	n/m	2020-04-29, From 2018-01-01
2017-12-31	-$2.37M	n/m	2019-03-29, From 2017-01-01
2016-12-31	-$2.23M	n/m	2018-04-02, From 2016-01-01
2015-12-31	-$1.03M	n/a	2017-05-08, From 2015-01-01
No annual figure between 2014-06-30 and 2015-12-31.
2014-06-30	-$975.0K	n/a	2015-09-25, From 2013-07-12

Operating Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Operating Income	Change YoY
Protagenic Therapeutics, Inc.\new (PTIX)	2026-03-31	-$4.50M	n/m
Bio-Path Holdings, Inc. (BPTH)	2024-12-31	-$11.99M	n/m
Pulmatrix, Inc. (PULM)	2025-12-31	-$5.17M	n/m
Lexaria Bioscience Corp. (LEXX)	2025-08-31	-$11.88M	n/m
Cadrenal Therapeutics, Inc. (CVKD)	2025-12-31	-$13.46M	n/m
Hepion Pharmaceuticals, Inc. (HEPA)	2025-12-31	-$4.16M	n/m
Alaunos Therapeutics, Inc. (TCRT)	2025-12-31	-$4.22M	n/m
Avenue Therapeutics, Inc. (ATXI)	2025-12-31	-$3.08M	n/m
Neonc Technologies Holdings, Inc. (NTHI)	2025-12-31	-$58.24M	n/m

Compare PTIX, BPTH, PULM, LEXX side by side · Screen every company in Pharmaceutical Preparations ↗